A New Jersey state court jury today awarded $10.6 million in compensation to a Utah woman who claims to have developed inflammatory bowel disease from taking Roche’s Accutane acne drug, according to Mealey’s.

The nine-member jury in the Atlantic County Superior Court ruled that the pill cause IBD, and Hoffman-La Roche failed to adequately warn the plaintiff, Kamie Kendall and her doctor, about Accutane’s IBD risks before April 1999. As a result, the failure to warn was the proximate cause of Kendall’s IBD. The jury voted 9-0 on those three questions, and voted 7-2 to award compensation of $78,500 for past medical expenses and $10.5 million in unspecified compensation. A source told Mealey that Judge Carol Higbee denied a motion to award punitive damages.

Kendall’s case was the second IBD case to go to trial in the New Jersey Accutane mass torts court. In June, a jury in the same court awarded $2.6 million in another IBD case. Last fall, a Florida jury decided Roche failed to adequately warn of Accutane’s risks and helped cause Crohn’s disease in an unemployed, 31-year-old welder, who took the drug for nine years. Roche, which was ordered to pay $7 million in that case, faces about 400 such lawsuits in different courts.